Author:
Weiland Anastasiia S.,Lu Julia Y.,Chen Caleb S.,Tjoa Thomas,Singh Raveena,McKinnell James A.,Miller Loren G.,Huang Susan S.
Abstract
ABSTRACTWe performed secondary analyses of a postdischarge decolonization trial of MRSA carriers that reduced MRSA infection and hospitalization by 30%. Hospitalized MRSA infection was associated with 7.9 days of non-MRSA antibiotics and CDI in 3.9%. Preventing MRSA infection and associated hospitalization may reduce antibiotic use and CDI incidence.
Publisher
Cambridge University Press (CUP)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference10 articles.
1. Clinical utility of infection control documentation of prior methicillin-resistant Staphylococcus aureus colonization or infection for optimization of empirical antibiotic therapy;Schweizer;Infect Control Hosp Epidemiol,2008
2. Decolonization to reduce postdischarge infection risk among MRSA Carriers;Huang;N Engl J Med,2019
3. 3. Multidrug-resistant organism and Clostridioides difficile Infection (MDRO/CDI) module. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf. Published 2020. Accessed June 9, 2020.
4. 8. Barrett, ML , Owens, PL. Clostridium difficile hospitalizations, 2011–2015. US Agency for Healthcare Research and Quality website. https://www.hcup-us.ahrq.gov/reports/HCUPCDiffHosp2011-2015Rpt081618.pdf. Published 2018. Accessed June 9, 2020.
5. Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans’ Affairs system;Huttner;J Antimicrob Chemother,2013